Oncology

Implementation of a Novel Remote Physician SBRT Coverage Process during the Coronavirus Pandemic
Alex Price, Lauren E. Henke, Borna Maraghechi, Taeho Kim, Matthew B. Spraker, Geoffrey D. Hugo, Clifford G. Robinson, Nels C. Knutson

medRxiv 2020.04.09.20059857; doi: https://doi.org/10.1101/2020.04.09.20059857

Add to Selected Citations
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre study
Olga Nigro, Graziella Pinotti, Federica De Galitiis, Francesca Romana Di Pietro, Raffaele Giusti, Marco Filetti, Melissa Bersanelli, Alessandro Lazzarin, Paola Bordi, Annamaria Catino, Pamela Pizzutilo, Domenico Galetta, Paolo Marchetti, Andrea Botticelli, Simone Scagnoli, Marco Russano, Daniele Santini, Mariangela Torniai, Rossana Berardi, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Alessandro Russo, Vincenzo Adamo, Marianna Tudini, Rosa Rita Silva, Elena Bolzacchini, Monica Giordano, Pietro Di Marino, Michele De Tursi, Erika Rijavec, Michele Ghidini, Ilaria Vallini, Luigia Stefania Stucci, Marco Tucci, Laura Pala, Fabio Conforti, Paola Queirolo, Enrica Tanda, Francesco Spagnolo, Federica Cecchi, Sergio Bracarda, Serena Macrini, Matteo Santoni, Nicola Battelli, Maria Concetta Fargnoli, Giampiero Porzio, Alessandro Tuzi, Matteo Basilio Suter, Corrado Ficorella, Alessio Cortellini

medRxiv 2020.04.09.20054031; doi: https://doi.org/10.1101/2020.04.09.20054031

Add to Selected Citations
Clinicopathologic correlates of pembrolizumab efficacy in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
Alessio Cortellini, Marcello Tiseo, Giuseppe L Banna, Federico Cappuzzo, Joachim GJV Aerts, Fausto Barbieri, Raffaele Giusti, Emilio Bria, Diego Cortinovis, Francesco Grossi, Maria R Migliorino, Domenico Galetta, Francesco Passiglia, Daniele Santini, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Vincenzo Di Noia, Diego Signorelli, Alessandro Tuzi, Alain Gelibter, Paolo Marchetti, Marianna Macerelli, Francesca Rastelli, Rita Chiari, Danilo Rocco, Stefania Gori, Michele De Tursi, Giovanni Mansueto, Federica Zoratto, Matteo Santoni, Marianna Tudini, Erika Rijavec, Marco Filetti, Annamaria Catino, Pamela Pizzutilo, Luca Sala, Fabrizio Citarella, Russano Marco, Mariangela Torniai, Luca Cantini, Giada Targato, Vincenzo Sforza, Olga Nigro, Miriam G Ferrara, Ettore D’Argento, Sebastiano Buti, Paola Bordi, Lorenzo Antonuzzo, Simona Scodes, Lorenza Landi, Giorgia Guaitoli, Cinzia Baldessari, Luigi Della Gravara, Maria Giovanna Dal Bello, Robert A. Belderbos, Paolo Bironzo, Simona Carnio, Serena Ricciardi, Alessio Grieco, Alessandro De Toma, Claudia Proto, Alex Friedlaender, Ornella Cantale, Biagio Ricciuti, Alfredo Addeo, Giulio Metro, Corrado Ficorella, Giampiero Porzio

medRxiv 2020.04.09.20047464; doi: https://doi.org/10.1101/2020.04.09.20047464

Add to Selected Citations
The Risk of Secondary Malignancies in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis
Keyvan Heydari, Sahar Rismantab, Reza Alizadeh-Navaei, Amir Shamshirian, Nima Shadmehri, Parisa Lotfi, Alieh Zamani-Kiasari, Danial Shamshirian

medRxiv 2020.04.07.20057190; doi: https://doi.org/10.1101/2020.04.07.20057190

Add to Selected Citations
Rapid Point-Of-Care Breath Test Predicts Breast Cancer And Abnormal Mammograms in Symptomatic Women
Michael Phillips, Therese B Bevers, Linda Hovanessian Larsen, Nadine Pappas, Sonali Pathak

medRxiv 2020.04.07.20042895; doi: https://doi.org/10.1101/2020.04.07.20042895

Add to Selected Citations
Hormone replacement therapy and elevated breast cancer risk: An artifact of growth acceleration?
Jutta Engel, Gabriele Schubert-Fritschle, Dieter Hölzel

medRxiv 2020.04.04.20050708; doi: https://doi.org/10.1101/2020.04.04.20050708

Add to Selected Citations
Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications
Aditi Bhatt, Naoual Bakrin, Praveen Kammar, Sanket Mehta, Snita Sinukumar, Loma Parikh, Sakina Shaikh, Suniti Mishra, Mita Y Shah, Vahan Kepenkian, Nazim Benzerdjeb, Olivier Glehen

medRxiv 2020.04.02.20048702; doi: https://doi.org/10.1101/2020.04.02.20048702

Add to Selected Citations
Risk of Secondary Malignancies in Patients with prostate cancer: A Systematic Review and Meta-analysis
Keyvan Heydari, Sahar Rismantab, Amir Shamshirian, Pouya Houshmand, Parisa Lotfi, Sajjad Rafati, Amir Aref, Ali Saravi, Danial Shamshirian, Behdad Zibaei, Reza Alizadeh-Navaei

medRxiv 2020.03.31.20049098; doi: https://doi.org/10.1101/2020.03.31.20049098

Add to Selected Citations
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma, Robert Olson, Stephen Harrow, Stewart Gaede, Alexander V. Louie, Cornelis Haasbeek, Liam Mulroy, Michael Lock, George B. Rodrigues, Brian P. Yaremko, Devin Schellenberg, Belal Ahmad, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Karen Moore, Suzanne Currie, Roel Schlijper, Glenn S. Bauman, Joanna Laba, X. Melody Qu, Andrew Warner, Suresh Senan

medRxiv 2020.03.26.20044305; doi: https://doi.org/10.1101/2020.03.26.20044305

Add to Selected Citations
Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer
Simon Heeke, Jonathan Benzaquen, Véronique Hofman, Elodie Long-Mira, Virginie Lespinet, Olivier Bordone, Charles-Hugo Marquette, Hervé Delingette, Marius Ilié, Paul Hofman

medRxiv 2020.03.28.20046102; doi: https://doi.org/10.1101/2020.03.28.20046102

Add to Selected Citations

Oncology

Pages